| Page No 1 2 |
| Phrase | Consultant | Town | Special Interests |
| Antibiotic resistance | *Consultant(s)* | *Towns* | Antibiotic resistance, beta-lactamases |
| Antibiotic resistance | *Consultant(s)* | *Towns* | Antibiotic resistance |
| antibiotic resistance | *Consultant(s)* | *Towns* | Clinical microbiology, antibiotic resistance, infection control |
| antibiotic resistance | *Consultant(s)* | *Towns* | Control of infection, HIV, septic shock, antifungal therapy, new diagnostics, infectious diseases, antibiotic resistance |
| Antibiotic resistance | *Consultant(s)* | *Towns* | Antibiotic resistance, MRSA screening |
| Antibiotic resistance | *Consultant(s)* | *Towns* | Antibiotic resistance |
| Antibiotic resistance | *Consultant(s)* | *Towns* | Antibiotic resistance |
| Antibiotic resistance | *Consultant(s)* | *Towns* | Antibiotic resistance, prevention and control of hospital acquired infections, Infections in the immunocompromised, medical education |
| antibiotic resistance | *Consultant(s)* | *Towns* | Infection control and prevention, clostridium difficile, MRSA, antibiotic resistance |
| antibiotic resistance | *Consultant(s)* | *Towns* | Acute lung infections, antibiotic resistance, medical education |
| antibiotic resistance | *Consultant(s)* | *Towns* | Hospital acquired infection, MRSA, antibiotic resistance, staphylococcus aureus infection, leptospirosis, molecular epidemiology |
| Antibiotic resistance | *Consultant(s)* | *Towns* | Antibiotic resistance |
| Antibiotic resistance | *Consultant(s)* | *Towns* | Antibiotic resistance, healthcare associated infections |
| antibiotic resistance | *Consultant(s)* | *Towns* | Medical microbiology, infections in critical care, surgical infections, diabetic foot infections, antibiotic prophylaxis, antibiotic resistance, infective endocarditis |
| antibiotic resistance | *Consultant(s)* | *Towns* | Infections in ICU - intensive care units, antibiotic resistance, infection in the immunocompromised |
| antibiotic resistance | *Consultant(s)* | *Towns* | Infection control, antibiotic resistance |
| antibiotic resistance in hospitals | *Consultant(s)* | *Towns* | Bacterial infection, healthcare associated infection, antibiotic resistance in hospitals, C difficile, helicobacter pylori, managing Carbapenemase resistance in hospitals, antimicrobial stewardship |
| antimicrobial drug resistance | *Consultant(s)* | *Towns* | TB - tuberculosis, mycobacterial diseases, antimicrobial drug resistance, pathogenesis of diseases |
| antimicrobial resistance | *Consultant(s)* | *Towns* | ICU - intensive care unit infections, Nosocomial infections, medical device related infections, near-patient testing for infections, antimicrobial resistance, infections in renal patients, transplant related infections, infection related emergencies, molecular diagnostics |
| antimicrobial resistance | *Consultant(s)* | *Towns* | Infection in immuocompromised, antimicrobial resistance |
| antimicrobial resistance | *Consultant(s)* | *Towns* | Sepsis, antimicrobial resistance |
| antimicrobial resistance | *Consultant(s)* | *Towns* | Sepsis, fever of unknown origin, infections in immunocompromised patients, septic shock, antimicrobial resistance |
| antimicrobial resistance | *Consultant(s)* | *Towns* | Neonatal sepsis, group B streptococci, antimicrobial resistance |
| Antimicrobial resistance | *Consultant(s)* | *Towns* | Antimicrobial resistance, prevention and control of hospital acquired infections |
| Antimicrobial resistance | *Consultant(s)* | *Towns* | Antimicrobial resistance, infection outcomes research, antimicrobial pharmacokinetics and dynamics, antibacterial drug development, medical microbiology |
| antimicrobial resistance | *Consultant(s)* | *Towns* | Sepsis, antimicrobial resistance |
| Antimicrobial resistance | *Consultant(s)* | *Towns* | Antimicrobial resistance, infection control |
| Antimicrobial resistance | *Consultant(s)* | *Towns* | Antimicrobial resistance |
| Antimicrobial resistance | *Consultant(s)* | *Towns* | Antimicrobial resistance, tropical infections |
| antimicrobial resistance | *Consultant(s)* | *Towns* | Tropical diseases in Vietnam, human and zoonotic influenza, antimicrobial resistance, hand, foot and mouth disease - not foot and mouth disease, emerging viral infections |
| Antimicrobial resistance | *Consultant(s)* | *Towns* | Antimicrobial resistance, nosocomial infection |
| antimicrobial resistance | *Consultant(s)* | *Towns* | Infection prevention and control, microbiology, clostridium difficile infection, antimicrobial resistance, infection diagnostics |
| antiretroviral resistance | *Consultant(s)* | *Towns* | HIV and AIDS, antiretroviral resistance |
| antiviral resistance | *Consultant(s)* | *Towns* | HIV, viral hepatitis, antiviral resistance, transplantation virology |
| antiviral resistance | *Consultant(s)* | *Towns* | Enterovirus infection, laboratory role in management of bloodborne viruses, virus infection in immunocompromised patients, antiviral resistance, application of NGS in diagnostic virology laboratory, clinical virology training |
| Drug resistance | *Consultant(s)* | *Towns* | Drug resistance, multiple myeloma, haematopoietic stem cell transplantation, lymphomas |
| drug resistance | *Consultant(s)* | *Towns* | General haematology, paediatric haematology, leukaemia, lymphoma, bone marrow transplantation, drug resistance, stem cell therapy |
| drug resistance in cancer treatment | *Consultant(s)* | *Towns* | Medical oncology, drug resistance in cancer treatment |
| endocrine resistance | *Consultant(s)* | *Towns* | Breast surgery, breast reconstruction, breast cancer, endocrine resistance, oncoplastic breast surgery |
| endocrine resistance in breast cancer | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, endocrine resistance in breast cancer |
| HIV drug resistance | *Consultant(s)* | *Towns* | HIV drug resistance, HIV women's services |
| HIV resistance | *Consultant(s)* | *Towns* | HIV resistance, antiretroviral toxicity, HIV and mental health |
| insulin resistance | *Consultant(s)* | *Towns* | Paediatric diabetes, obesity, insulin resistance |
| insulin resistance | *Consultant(s)* | *Towns* | Hypertension, diabetes, insulin resistance, endothelium |
| insulin resistance | *Consultant(s)* | *Towns* | Reproductive endocrinology, insulin resistance, non-alcoholic fatty liver disease - NAFLD, obesity, diabetes |
| insulin resistance and cardiovascular risk in diabetes | *Consultant(s)* | *Towns* | Endocrinology, insulin resistance and cardiovascular risk in diabetes, polycystic ovary syndrome - PCOS, the diabetic foot, female hirsutism, general endocrine disorders, neuroendocrine disorders, pituitary disorders |
| insulin resistance syndrome | *Consultant(s)* | *Towns* | Diabetes, insulin resistance syndrome, metabolic disorders and cardiovascular disease, obesity, lipids |
| insulin resistance syndrome in obesity | *Consultant(s)* | *Towns* | Paediatric diabetes and endocrinology, insulin resistance syndrome in obesity |
| managing Carbapenemase resistance in hospitals | *Consultant(s)* | *Towns* | Bacterial infection, healthcare associated infection, antibiotic resistance in hospitals, C difficile, helicobacter pylori, managing Carbapenemase resistance in hospitals, antimicrobial stewardship |
| resistance to antibiotics | *Consultant(s)* | *Towns* | Virology, infection control, resistance to antibiotics |
| Page No 1 2 |
